首页> 外文期刊>The Internet Journal of Emergency Medicine >Snake-bite Envenomation: A Comprehensive Evaluation of Severity, Treatment and Outcome in a tertiary Care South Indian Hospital
【24h】

Snake-bite Envenomation: A Comprehensive Evaluation of Severity, Treatment and Outcome in a tertiary Care South Indian Hospital

机译:蛇咬毒瘾:南印度三级医院的严重程度,治疗和结果的综合评估

获取原文
           

摘要

Snake bite is a known cause for increased morbidity and mortality in India. A six year retrospective review of medical records was carried out to study the trends, epidemiology, snakebite severity, treatment, and outcome among 252 patients of snakebite in a tertiary care South Indian hospital. Severity assessment showed an average grade of 3.3 with moderate injury. Hemotoxicity and Cellulitis was the most common complications among unidentified snake bites and cobra bites. An average of 11.9 ± 9.3 vials (N=2994) were administered and 96 (48%) anaphylactic reactions were observed. The mortality rate was 10.7% (n=27) while 78.9%of patients improved with 8.2±8.3 day hospitalization period. Severity scores, complications and outcomes were significantly associated with type of snakes, age distribution and linearly correlated to the time elapsed between snake bite instance and hospitalization. Mortality and morbidity can be minimised by the early interventions following identification of snakes, associated sign, symptoms and severity. Introduction In India, it is estimated that up to 20,000 people die annually from snake bites. Morbidity is also significant and there seems to have been little improvement in reducing the fatalities over the years in spite of now having good supplies of polyvalent anti-snake venom (ASV) available in all population centers. The major reason for high mortality rate (about 5% to 10% of all those reporting bites) is the delay in getting the victim to a well-equipped casualty treatment facility fast enough. Snake bite, an important cause of death in rural patients in developing countries, is a neglected public health problem. Worldwide, of the estimated 5 million people bitten by snakes each year, about 1,25,000 die. 1 More than 2,00,000 cases of snake bite are reported in India each year and 35,000–50,000 of them have turned out to be fatal. Reports from Maharashtra, State in India, disclose that an estimated 10,000 annual venomous snake bites account for 2000 deaths. 2 Romulus Whitaker, pointed out that, the Indian cobra (Naja naja), the common krait (Bungarus caeruleus), the Russell's viper (Daboia russelii) and the sawscaled viper (Echis carinatus) are basically four venomous snakes found in India. He called them the “Big Four” which are mainly responsible for Indian snake bite mortality. 3 The concept of the ‘‘Big Four'‘ restricts sound epidemiological work and the development of effective snake antivenoms. It should be replaced by the model introduced in the 1980s by the World Health Organization, which has not received adequate circulation and implementation. 4The type of snake bite varies from region to region. Wherever one species prevails, the chances of humans coming into their contact is higher, then the bite of that species will be more common. 3 Snake bite is continuing to be a major medical concern in India. World Health Organization survey reports that 1.2–2.4 deaths occur per 100,000 victims with a mortality level of 25,000 per annum. There are many causal factors that contribute to this mortality rate, and many questions remain unanswered. To make more meaningful use of resources such as antivenom, ventilator therapy and renal support systems in patients with snake bite, it is important that the healthcare providers aptly identify those at high risk of potentially fatal complications. Simple demographic and clinical characteristics could be used to help doctors distinguish between high-risk and low-risk patients. To be useful, the predictors like snake bite severity score should be simple, accurate and clinically credible. There has, however, been very little qualitative herpetological work in India, since the 1940s. Limited statistics on mortality and morbidity due to envenomation are available. Such data have recognizable limitations. 4 There are very limited Indian studies which have assessed severity and its role in predicting outcome of snake envenomation. The factors, like time-lags
机译:蛇咬伤是印度发病率和死亡率增加的已知原因。在南印度一家三级医院,对病历进行了为期六年的回顾性研究,以研究252位蛇咬伤患者的趋势,流行病学,蛇咬伤严重程度,治疗和结局。严重程度评估显示平均等级为3.3,伴有中度伤害。血液中毒和蜂窝组织炎是蛇咬和眼镜蛇咬伤中最常见的并发症。平均给药11.9±9.3小瓶(N = 2994),观察到96例(48%)过敏反应。住院率为8.2±8.3天,死亡率为10.7%(n = 27),而78.9%的患者病情好转。严重程度评分,并发症和结局与蛇的类型,年龄分布显着相关,并且与蛇咬伤实例和住院之间的时间呈线性关系。通过识别蛇,相关体征,症状和严重性后的早期干预,可以使死亡率和发病率降至最低。引言在印度,据估计每年有2万人死于蛇咬。发病率也很重要,尽管现在所有人口中心都有充足的多价抗蛇毒(ASV)供应,但多年来减少死亡人数似乎没有什么改善。高死亡率(占所有被叮咬者的5%到10%)是造成死亡率高的主要原因,这是因为延误了足够快地将受害者送往设备完善的伤亡治疗设施。蛇咬伤是发展中国家农村患者死亡的重要原因,是被忽视的公共卫生问题。在全球范围内,每年估计有500万人被蛇咬伤,其中约有12.5万人死亡。 1印度每年报告超过2,000,000例蛇咬病例,其中35,000–50,000被证明是致命的。印度国家马哈拉施特拉邦的报告显示,估计每年有10,000例毒蛇咬伤,造成2000人死亡。 2罗缪勒斯·惠特克(Romulus Whitaker)指出,印度眼镜蛇(Naja naja),常见的蛇类(Bungarus caeruleus),罗素的s蛇(Daboia russelii)和锯齿vi蛇(Echis carinatus)基本上是在印度发现的四毒蛇。他称它们为“四大”,主要是造成印度蛇咬伤的原因。 3“四大”概念限制了合理的流行病学工作和有效的蛇抗蛇毒素的发展。应该用世界卫生组织在1980年代引入的模型代替该模型,该模型尚未得到充分的流通和实施。 4蛇咬的类型因地区而异。无论哪种物种盛行,人类接触的机会都更高,那么这种物种的叮咬就会更加普遍。 3蛇咬伤仍是印度的主要医疗问题。世界卫生组织的调查报告称,每10万名受害者中有1.2至2.4例死亡,每年的死亡率为25,000。造成这一死亡率的因素很多,许多问题仍未得到解答。为了在蛇咬伤患者中更有意义地利用诸如抗蛇毒杆菌,呼吸机治疗和肾脏支持系统等资源,重要的是,医疗服务提供者应适当地识别那些具有致命致命并发症高风险的人。简单的人口统计学和临床​​特征可用于帮助医生区分高危和低危患者。为了有用,像蛇咬伤严重程度评分这样的预测因素应该简单,准确并且在临床上可靠。但是,自1940年代以来,印度很少进行定性的爬虫工作。目前尚无有关毒死的死亡率和发病率的统计数据。此类数据具有可识别的局限性。 4印度很少有研究评估了蛇毒的严重程度及其在预测蛇毒化结果中的作用。诸如时滞之类的因素

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号